Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc..
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Nature medicine - 29(2023), 10 vom: 05. Okt., Seite 2438-2457 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 06.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41591-023-02502-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362879850 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362879850 | ||
| 003 | DE-627 | ||
| 005 | 20240406232027.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41591-023-02502-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM362879850 | ||
| 035 | |a (NLM)37794253 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tobias, Deirdre K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 06.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
| 520 | |a Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Merino, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Abrar |e verfasserin |4 aut | |
| 700 | 1 | |a Aiken, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Benham, Jamie L |e verfasserin |4 aut | |
| 700 | 1 | |a Bodhini, Dhanasekaran |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Amy L |e verfasserin |4 aut | |
| 700 | 1 | |a Colclough, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Corcoy, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Cromer, Sara J |e verfasserin |4 aut | |
| 700 | 1 | |a Duan, Daisy |e verfasserin |4 aut | |
| 700 | 1 | |a Felton, Jamie L |e verfasserin |4 aut | |
| 700 | 1 | |a Francis, Ellen C |e verfasserin |4 aut | |
| 700 | 1 | |a Gillard, Pieter |e verfasserin |4 aut | |
| 700 | 1 | |a Gingras, Véronique |e verfasserin |4 aut | |
| 700 | 1 | |a Gaillard, Romy |e verfasserin |4 aut | |
| 700 | 1 | |a Haider, Eram |e verfasserin |4 aut | |
| 700 | 1 | |a Hughes, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Ikle, Jennifer M |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobsen, Laura M |e verfasserin |4 aut | |
| 700 | 1 | |a Kahkoska, Anna R |e verfasserin |4 aut | |
| 700 | 1 | |a Kettunen, Jarno L T |e verfasserin |4 aut | |
| 700 | 1 | |a Kreienkamp, Raymond J |e verfasserin |4 aut | |
| 700 | 1 | |a Lim, Lee-Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Männistö, Jonna M E |e verfasserin |4 aut | |
| 700 | 1 | |a Massey, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Mclennan, Niamh-Maire |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Rachel G |e verfasserin |4 aut | |
| 700 | 1 | |a Morieri, Mario Luca |e verfasserin |4 aut | |
| 700 | 1 | |a Most, Jasper |e verfasserin |4 aut | |
| 700 | 1 | |a Naylor, Rochelle N |e verfasserin |4 aut | |
| 700 | 1 | |a Ozkan, Bige |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Kashyap Amratlal |e verfasserin |4 aut | |
| 700 | 1 | |a Pilla, Scott J |e verfasserin |4 aut | |
| 700 | 1 | |a Prystupa, Katsiaryna |e verfasserin |4 aut | |
| 700 | 1 | |a Raghavan, Sridharan |e verfasserin |4 aut | |
| 700 | 1 | |a Rooney, Mary R |e verfasserin |4 aut | |
| 700 | 1 | |a Schön, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Semnani-Azad, Zhila |e verfasserin |4 aut | |
| 700 | 1 | |a Sevilla-Gonzalez, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Svalastoga, Pernille |e verfasserin |4 aut | |
| 700 | 1 | |a Takele, Wubet Worku |e verfasserin |4 aut | |
| 700 | 1 | |a Tam, Claudia Ha-Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Thuesen, Anne Cathrine B |e verfasserin |4 aut | |
| 700 | 1 | |a Tosur, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Wallace, Amelia S |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Caroline C |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Jessie J |e verfasserin |4 aut | |
| 700 | 1 | |a Yamamoto, Jennifer M |e verfasserin |4 aut | |
| 700 | 1 | |a Young, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Amouyal, Chloé |e verfasserin |4 aut | |
| 700 | 1 | |a Andersen, Mette K |e verfasserin |4 aut | |
| 700 | 1 | |a Bonham, Maxine P |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Mingling |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Feifei |e verfasserin |4 aut | |
| 700 | 1 | |a Chikowore, Tinashe |e verfasserin |4 aut | |
| 700 | 1 | |a Chivers, Sian C |e verfasserin |4 aut | |
| 700 | 1 | |a Clemmensen, Christoffer |e verfasserin |4 aut | |
| 700 | 1 | |a Dabelea, Dana |e verfasserin |4 aut | |
| 700 | 1 | |a Dawed, Adem Y |e verfasserin |4 aut | |
| 700 | 1 | |a Deutsch, Aaron J |e verfasserin |4 aut | |
| 700 | 1 | |a Dickens, Laura T |e verfasserin |4 aut | |
| 700 | 1 | |a DiMeglio, Linda A |e verfasserin |4 aut | |
| 700 | 1 | |a Dudenhöffer-Pfeifer, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Evans-Molina, Carmella |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Balsells, María Mercè |e verfasserin |4 aut | |
| 700 | 1 | |a Fitipaldi, Hugo |e verfasserin |4 aut | |
| 700 | 1 | |a Fitzpatrick, Stephanie L |e verfasserin |4 aut | |
| 700 | 1 | |a Gitelman, Stephen E |e verfasserin |4 aut | |
| 700 | 1 | |a Goodarzi, Mark O |e verfasserin |4 aut | |
| 700 | 1 | |a Grieger, Jessica A |e verfasserin |4 aut | |
| 700 | 1 | |a Guasch-Ferré, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Habibi, Nahal |e verfasserin |4 aut | |
| 700 | 1 | |a Hansen, Torben |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Chuiguo |e verfasserin |4 aut | |
| 700 | 1 | |a Harris-Kawano, Arianna |e verfasserin |4 aut | |
| 700 | 1 | |a Ismail, Heba M |e verfasserin |4 aut | |
| 700 | 1 | |a Hoag, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Randi K |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Angus G |e verfasserin |4 aut | |
| 700 | 1 | |a Koivula, Robert W |e verfasserin |4 aut | |
| 700 | 1 | |a Leong, Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a Leung, Gloria K W |e verfasserin |4 aut | |
| 700 | 1 | |a Libman, Ingrid M |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Kai |e verfasserin |4 aut | |
| 700 | 1 | |a Long, S Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Lowe, William L |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Morton, Robert W |e verfasserin |4 aut | |
| 700 | 1 | |a Motala, Ayesha A |e verfasserin |4 aut | |
| 700 | 1 | |a Onengut-Gumuscu, Suna |e verfasserin |4 aut | |
| 700 | 1 | |a Pankow, James S |e verfasserin |4 aut | |
| 700 | 1 | |a Pathirana, Maleesa |e verfasserin |4 aut | |
| 700 | 1 | |a Pazmino, Sofia |e verfasserin |4 aut | |
| 700 | 1 | |a Perez, Dianna |e verfasserin |4 aut | |
| 700 | 1 | |a Petrie, John R |e verfasserin |4 aut | |
| 700 | 1 | |a Powe, Camille E |e verfasserin |4 aut | |
| 700 | 1 | |a Quinteros, Alejandra |e verfasserin |4 aut | |
| 700 | 1 | |a Jain, Rashmi |e verfasserin |4 aut | |
| 700 | 1 | |a Ray, Debashree |e verfasserin |4 aut | |
| 700 | 1 | |a Ried-Larsen, Mathias |e verfasserin |4 aut | |
| 700 | 0 | |a et al |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature medicine |d 1995 |g 29(2023), 10 vom: 05. Okt., Seite 2438-2457 |w (DE-627)NLM074659804 |x 1546-170X |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:10 |g day:05 |g month:10 |g pages:2438-2457 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41591-023-02502-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 10 |b 05 |c 10 |h 2438-2457 | ||